4586 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Medrx Co. Ltd. engages in the business of pharmaceutical drug development based on the transdermal absorption. It develops new value-added medicines by the drug formulation technology based on ILTS (Ionic Liquid Transdermal System), a unique technologies using ionic liquid and unique transdermal drug delivery technology using nano-sized colloid transdermal system for drugs. The company was founded by Masayoshi Matsumura on January 15, 2002 and is headquartered in Higashikagawa, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
4586 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company